Neurocrine Biosciences (NASDAQ: NBIX) delivered a decisive earnings beat in Q3, posting adjusted EPS of $2.17 against ...
The Nashville, Tennessee-based company operates general and acute care hospitals, outpatient healthcare facilities, and behavioral hospitals, which provide therapeutic programs comprising child, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback